日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial

索拉非尼联合多柔比星与索拉非尼单药治疗晚期肝细胞癌患者的疗效评估:CALGB 80802 III期随机临床试验

Abou-Alfa, Ghassan K; Shi, Qian; Knox, Jennifer J; Kaubisch, Andreas; Niedzwiecki, Donna; Posey, James; Tan, Benjamin R Jr; Kavan, Petr; Goel, Rakesh; Lammers, Philip E; Bekaii-Saab, Tanios S; Tam, Vincent C; Rajdev, Lakshmi; Kelley, Robin K; El Dika, Imane; Zemla, Tyler; Potaracke, Ryan I; Balletti, Jennifer; El-Khoueiry, Anthony B; Harding, James J; Suga, Jennifer M; Schwartz, Lawrence H; Goldberg, Richard M; Bertagnolli, Monica M; Meyerhardt, Jeffrey; O'Reilly, Eileen M; Venook, Alan P

Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study

多学科肿瘤委员会在胰腺和上消化道疾病管理中的作用:一项观察性研究

Brauer, David G; Strand, Matthew S; Sanford, Dominic E; Kushnir, Vladimir M; Lim, Kian-Huat; Mullady, Daniel K; Tan, Benjamin R Jr; Wang-Gillam, Andrea; Morton, Ashley E; Ruzinova, Marianna B; Parikh, Parag J; Narra, Vamsi R; Fowler, Kathryn J; Doyle, Majella B; Chapman, William C; Strasberg, Steven S; Hawkins, William G; Fields, Ryan C

Complete response and prolonged disease-free survival in a patient with recurrent duodenal adenocarcinoma treated with bevacizumab plus FOLFOX6

接受贝伐珠单抗联合FOLFOX6方案治疗的复发性十二指肠腺癌患者获得完全缓解和延长的无病生存期。

Nagaraj, Gayathri; Zarbalian, Yousef; Flora, Karin; Tan, Benjamin R Jr

Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer

胰腺癌患者循环间皮素蛋白和细胞抗间皮素免疫

Johnston, Fabian Mc; Tan, Marcus C B; Tan, Benjamin R Jr; Porembka, Matthew R; Brunt, Elizabeth M; Linehan, David C; Simon, Peter O Jr; Plambeck-Suess, Stacey; Eberlein, Timothy J; Hellstrom, Karl Erik; Hellstrom, Ingegerd; Hawkins, William G; Goedegebuure, Peter